What does Nautilus Biotechnology, Inc. do?

Jun 22 2025 07:11 PM IST
share
Share Via
Nautilus Biotechnology, Inc. is a blank check company targeting business combinations in the healthcare sector, particularly in life sciences and medical technology. As of March 2025, it has a market cap of $88.38 million and reported a net profit loss of $17 million.
Overview:
Nautilus Biotechnology, Inc. is a blank check company focused on effecting business combinations in the healthcare industry, particularly within the life sciences and medical technology sectors, and operates in the Pharmaceuticals & Biotechnology industry with a micro-cap market capitalization.

Financial Snapshot:
Net Profit: -17 Million (Quarterly Results - Mar 2025)
Market Cap: USD 88.38 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.69
Return on Equity: -35.31%
Price to Book: 0.45

Contact Details:
Address: 51 Astor Place, 10Th Floor, NEW YORK NY: 10003
Tel: 1 212 2842300
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Nautilus Biotechnology, Inc.?
Jun 22 2025 06:21 PM IST
share
Share Via